Do you want to read an article? Please log in or register.
α1-antitrypsin promotes lung adenocarcinoma metastasis through upregulating fibronectin expression
Lung, Respiratory and Thoracic Cancer
Related content
Lymphoma
PD-L1 expression in lung adenocarcinoma harboring EGFR mutations or ALK rearrangements
Lung Cancer.
Yoneshima Y, Ijichi K, Anai S, Ota K, Otsubo K, Iwama E, Tanaka K, Oda Y, Nakanishi Y, Okamoto I
doi: 10.1016/
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naïve advanced EGFR-mutant lung adenocarcinoma patients
Lung Cancer.
Hsu KH, Huang YH, Tseng JS, Chen KC, Ku WH, Su KY, Chen JJW, Chen HW, Yu SL, Yang TY, Chang GC
doi: 10.1016/j.lungcan.2018.11.021.
Lung, Respiratory and Thoracic Cancer
Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas
Ann Oncol.
Schoenfeld AJ, Rizvi H, Bandlamudi C, Sauter JL, Travis WD, Rekhtman N, Plodkowski AJ, Perez-Johnston R, Sawan P, Beras A, Egger JV, Ladanyi M, Arbour KC, Rudin CM, Riely GJ, Taylor BS, Donoghue MTA, Hellmann MD
doi: 10.1016/j.annonc.2020.01.065.
Lung, Respiratory and Thoracic Cancer
A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma
Oncoimmunology
Budczies J, Kirchner M, Kluck K, Kazdal D, Glade J, Allgäuer M, Kriegsmann M, Heußel CP, Herth FJ, Winter H, Meister M, Muley T, Fröhling S, Peters S, Seliger B, Schirmacher P, Thomas M, Christopoulos P, Stenzinger A
doi: 10.1080/2162402X.2020.1860586
Lung, Respiratory and Thoracic Cancer
Glut1 expression in tumor-associated neutrophils promotes lung cancer growth and resistance to radiotherapy
Cancer Res
Ancey PB, Contat C, Boivin G, Sabatino S, Pascual J, Zangger N, Perentes JY, Peters S, Abel ED, Kirsch DG, Rathmell JC, Vozenin MC, Meylan E
doi: 10.1158/0008-5472.CAN-20-2870
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Non-interventional LUME-BioNIS study of nintedanib plus docetaxel after chemotherapy in adenocarcinoma non-small cell lung cancer: A subgroup analysis in patients with prior immunotherapy
★ 1
Recommended by
Dr Wolf-Dieter Janthur, Faculty Member
Lung Cancer.
Reck M, Syrigos K, Miliauskas S, Zöchbauer-Müller S, Fischer JR, Buchner H, Kitzing T, Kaiser R, Radonjic D, Kerr K
doi: 10.1016/j.lungcan.2020.08.004.
Lymphoma
Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 ≥50% Expression in Lung Adenocarcinoma
J Thorac Oncol.
Rangachari D, VanderLaan PA, Shea M, Le X, Huberman MS, Kobayashi SS, Costa DB
doi: 10.1016/j.jtho.2016.12.026.
Central Nervous System TumorsLung, Respiratory and Thoracic Cancer
An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer
Eur J Cancer.
Tsakonas G, Lewensohn R, Botling J, Ortiz-Villalon C, Micke P, Friesland S, Nord H, Lindskog M, Sandelin M, Hydbring P, Ekman S
doi: 10.1016/j.ejca.2020.03.014.
Lung, Respiratory and Thoracic Cancer
Characteristics and outcomes of patients with metastatic KRAS mutant lung adenocarcinomas: The Lung Cancer Mutation Consortium experience
J Thorac Oncol.
El Osta B, Behera M, Kim S, Berry LD, Sica G, Pillai RN, Owonikoko TK, Kris MG, Johnson BE, Kwiatkowski DJ, Sholl LM, Aisner DL, Bunn PA, Khuri FR, Ramalingam SS
doi: 10.1016/j.jtho.2019.01.020.